Gpt Healthcare Limited (GPTHEALTH)

Loading page…

Gpt Healthcare Limited (GPTHEALTH) · mywealthgrid

Financials

Reported profit and loss, balance sheet, cash flow and growth history.

Standalone figures · ₹ crore

₹ Cr	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	361	400	407	473
COGS	76	83	79	90
Gross profit	285	317	328	383
	211	229	245	299
	74	88	83	84
OPM %	20.6%	22%	20.5%	17.8%
Depreciation	15	18	19	27
Interest	9	7	3	8
	6	5	8	6
Profit before tax	56	68	69	55
Tax	17	20	19	13
Tax %	30.3%	29.8%	28%	23%
	39	48	50	42
PAT margin %	10.8%	11.9%	12.3%	8.9%
EPS (₹)	4.9	6	6.1	5.2
EPS adjusted (₹)	4.9	5.8	6.1	5.2
	0%	25.2%	57.6%	48.5%
Annual report	—	Annual report for Mar 2024	Annual report for Mar 2025	Annual report for Mar 2026

₹ Cr	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity capital	80	80	82	82	82
Reserves	—	85	136	166	187
Minority interest	—	—	—	—	0
	—	65	12	13	16
	—	97	115	123	179
Total equity & liabilities	—	327	346	384	465
	220	228	202	204	266
CWIP	—	3	6	46	1
Investments	—	13	30	32	43
	—	83	107	102	155
Total assets	—	327	346	384	465

₹ Cr	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	66	69	67	81
	5	-25	-33	-47
	-73	-49	-35	-31
Net cash flow	-2	-5	-0	2
Free cash flow	57	49	17	39
CFO / Operating profit %	89.3%	78.3%	80.9%	96.4%

Compounded sales growth

7 years: —
5 years: —
3 years: 9%
1 year: 16%

Compounded profit growth

7 years: —
5 years: —
3 years: 3%
1 year: -15%

Return on equity

7 years: —
5 years: —
3 years: 19%
Last year: 16%

Loading financials…

Ratios

Annual operating, return, leverage and working-capital ratios.

Standalone figures

Ratio	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	79%	79.3%	80.6%	81%
EBITDA margin %	20.6%	22%	20.5%	17.8%
EBIT margin %	16.5%	17.5%	15.8%	12.1%
PAT margin %	10.8%	11.9%	12.3%	8.9%
Working capital
Receivable days	21	22	22	16
Inventory days	43	36	41	43
Payable days	161	165	161	170
NWC days	-97	-107	-98	-112
Leverage
Current ratio	0.99	1.04	1.06	1.12
Debt to EBITDA	0.87	0.14	0.16	0.19
Debt to equity	0.39	0.06	0.05	0.06
Interest coverage	7.1	10.6	21	7.7
Asset turnover	1.1	1.16	1.06	1.02
Return ratios
Return on assets %	11.9%	13.8%	13%	9.1%
Return on capital employed %	26.6%	29.3%	25.2%	18.1%
Return on equity %	23.6%	21.9%	20.1%	15.7%

Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.

Loading ratios…

Shareholding

Quarterly ownership, named holders, insider transactions and disclosed deals.

Quarterly Annual

Every quarter filed · % of equity

Holder (%)	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	65.57%	65.57%	65.57%	65.57%	65.57%	65.57%	65.57%	65.57%	65.57%	65.57%	65.57%
	7.13%	6.68%	5.38%	4.7%	4.72%	4.48%	4.96%	3.2%	2.74%	2.81%	3.03%
	10.07%	12.81%	13.08%	11.99%	11.3%	11.35%	9.32%	6.46%	6.2%	6.83%	6.94%
Government	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
	17.23%	14.94%	15.97%	17.74%	18.41%	18.6%	20.15%	24.77%	25.49%	24.79%	24.46%
No. of shareholders	—	—	—	—	—	—	—	67,617	66,626	64,075	62,454

Promoter holding up 0 percentage points since Dec 2023.

16 deals · 29 Feb 2024 – 27 Mar 2026

Date	Client	Type	Venue	Side	Quantity	Price	Value
27 Mar 2026	SHREE CAPITAL SERVICES LTD	Bulk	NSE	Sell	5,62,000	₹117.95	₹6.63 Cr
27 Mar 2026	N B I INDUSTRIAL FINANCE COMPANY LIMITED	Bulk	NSE	Buy	5,61,900	₹117.98	₹6.63 Cr
25 Mar 2026	DIGVIJAY FINLEASE LIMITED	Bulk	NSE	Sell	4,67,000	₹121.42	₹5.67 Cr
12 Sept 2024	GRAVITON RESEARCH CAPITAL LLP	Bulk	NSE	Sell	6,85,574	₹197.86	₹13.56 Cr
12 Sept 2024	GRAVITON RESEARCH CAPITAL LLP	Bulk	NSE	Buy	6,85,574	₹197.71	₹13.55 Cr
19 Aug 2024	GRAVITON RESEARCH CAPITAL LLP	Bulk	NSE	Sell	4,81,731	₹187.96	₹9.05 Cr
19 Aug 2024	GRAVITON RESEARCH CAPITAL LLP	Bulk	NSE	Buy	4,81,731	₹187.89	₹9.05 Cr
29 Feb 2024	GRT STRATEGIC VENTURES LLP	Bulk	NSE	Buy	8,91,061	₹207.02	₹18.45 Cr
29 Feb 2024	GRT STRATEGIC VENTURES LLP	Bulk	NSE	Sell	8,91,061	₹207.11	₹18.45 Cr
29 Feb 2024	MARWADI CHANDARANA INTERMEDIARIES BROKERS PRIVATE LIMITED	Bulk	NSE	Sell	7,05,929	₹203.29	₹14.35 Cr

1–10 of 16

1 / 2

Mr. Om TantiaExecutive Director-Chairperson related to Promoter-MD
Mr. Shree Gopal TantiaVice Chairperson
Mr. Shree Gopal TantiaNon-Executive - Non Independent Director
Mr. Anurag TantiaExecutive Director
Mrs. Aruna TantiaNon-Executive - Non Independent Director
Mr. Ghanshyam GoyalNon-Executive - Non Independent Director
Mr. Kashi Prasad KhandelwalNon-Executive - Independent Director
Mrs. Tapti SenNon-Executive - Independent Director
Mr. Hari ModiNon-Executive - Independent Director
Mr. Deepak PramanikNon-Executive - Independent Director
Mr. Amrendra Prasad VermaNon-Executive - Independent Director

Loading shareholding…

Fund holders

Mutual-fund schemes that disclosed a holding in the company.

Portfolio month

Schemes holding

across 1 fund houses

Held by these funds

of the company's equity

All mutual funds

4.65%

shareholding pattern, Jun 2026

Portfolios as of

August 2026

compared with July 2026

1 schemes

		Shares
(Investment Manager for Motilal Oswal Mutual Fund)	Motilal Oswal Mutual Fund	765	0.01	0.03%	0.001%	+1

Loading fund holders…

Announcements

Latest exchange announcements, filings and downloadable documents.

1 month 3 months 6 months 1 year All

34 announcementsExport CSV

28 Sept 2026, 10:18 amInsider Trading / SAST

Closure of Trading Window

Closure of Trading Window PDF

21 Sept 2026, 3:52 pmCompany Update

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Analyst / Investor Meet PDF

7 Aug 2026, 7:44 pmCompany Update

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

Earnings Call Transcript PDF

7 Aug 2026, 5:15 pmAGM/EGM

Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

AGM PDF

3 Aug 2026, 5:25 pmCompany Update

Announcement under Regulation 30 (LODR)-Press Release / Media Release

Press Release / Media Release PDF

3 Aug 2026, 5:21 pmCompany Update

Announcement under Regulation 30 (LODR)-Investor Presentation

Investor Presentation PDF

3 Aug 2026, 4:46 pmResult

Un-Audited Financial Results For Q1FY2027

Financial Results PDF

3 Aug 2026, 4:34 pmBoard Meeting

Board Meeting Outcome for Outcome Of Board Meeting Held On August 3, 2026

Outcome of Board Meeting PDF

Date	Category	Subject	Filing
28 Sept 2026, 10:18 am	Insider Trading / SAST Closure of Trading Window	Closure of Trading Window	PDF
21 Sept 2026, 3:52 pm	Company Update Analyst / Investor Meet	Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Loading announcements…

Ratio	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	79%	79.3%	80.6%	81%
EBITDA margin %	20.6%	22%	20.5%	17.8%
EBIT margin %	16.5%	17.5%	15.8%	12.1%
PAT margin %	10.8%	11.9%	12.3%	8.9%
Working capital
Receivable days	21	22	22	16
Inventory days	43	36	41	43
Payable days	161	165	161	170
NWC days	-97	-107	-98	-112
Leverage
Current ratio	0.99	1.04	1.06	1.12
Debt to EBITDA	0.87	0.14	0.16	0.19
Debt to equity	0.39	0.06	0.05	0.06
Interest coverage	7.1	10.6	21	7.7
Asset turnover	1.1	1.16	1.06	1.02
Return ratios
Return on assets %	11.9%	13.8%	13%	9.1%
Return on capital employed %	26.6%	29.3%	25.2%	18.1%
Return on equity %	23.6%	21.9%	20.1%	15.7%

Company	Mkt Cap	EV	Revenue	EBITDA	OPM	PAT	NPM	ROCE	ROE	WC Days
Max Healthcare Institute LimitedMAXHEALTHMAXHEALTH	₹91,573 Cr	₹95,052 Cr	₹8,712 Cr	₹2,318 Cr	26.8%	₹1,457 Cr	17.2%	13.8%	14.3%	-110
Manipal Health Enterprises LimitedMANIPALHOSMANIPALHOS	₹91,552 Cr	₹1,02,105 Cr	₹10,336 Cr	₹2,611 Cr	25.3%	₹917 Cr	8.9%	12.5%	12.8%	38
Fortis Healthcare LimitedFORTISFORTIS	₹59,268 Cr	₹62,140 Cr	₹9,506 Cr	₹2,131 Cr	22.8%	₹1,048 Cr	11.7%	13%	11.1%	-99
Aster Dm Healthcare LimitedASTERDMASTERDM	₹36,728 Cr	₹37,429 Cr	₹4,876 Cr	₹958 Cr	19.4%	₹319 Cr	9.2%	11.9%	9.7%	-112
Global Health LimitedMEDANTAMEDANTA	₹36,498 Cr	₹37,688 Cr	₹4,683 Cr	₹979 Cr	20.8%	₹556 Cr	12.6%	16.9%	15.1%	-26
Narayana Hrudayalaya Ltd.NHNH	₹35,594 Cr	₹40,460 Cr	₹9,072 Cr	₹1,749 Cr	20.5%	₹816 Cr	10.2%	15.1%	19.7%	-181
Krishna Institute Of Medical Sciences LimitedKIMSKIMS	₹29,457 Cr	₹32,701 Cr	₹4,213 Cr	₹833 Cr	20.5%	₹205 Cr	6.2%	9.5%	11%	-50
Dr. Agarwal's Health Care LimitedAGARWALEYEAGARWALEYE	₹15,420 Cr	₹15,578 Cr	₹2,207 Cr	₹612 Cr	27.4%	₹148 Cr	8.1%	10.1%	6.8%	-76
Rainbow Childrens Medicare LimitedRAINBOWRAINBOW	₹13,003 Cr	₹13,003 Cr	₹1,820 Cr	₹575 Cr	32%	₹285 Cr	16.5%	18.2%	17.9%	-73
Park Medi World LimitedPARKHOSPSPARKHOSPS	₹11,696 Cr	₹11,924 Cr	₹1,679 Cr	₹444 Cr	26.5%	₹258 Cr	16.3%	21.4%	16.7%	-2
Healthcare Global Enterprises LimitedHCGHCG	₹9,984 Cr	₹10,895 Cr	₹2,627 Cr	₹480 Cr	18.3%	₹23 Cr	0.9%	9.1%	1.2%	-93
Yatharth Hospital & Trauma Care Services LimitedYATHARTHYATHARTH	₹9,965 Cr	₹10,218 Cr	₹1,334 Cr	₹310 Cr	24.2%	₹174 Cr	14.1%	12.3%	10%	-26

Gpt Healthcare Limited

About

Key insights

Key risks

Growth drivers

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Compounded sales growth

Compounded profit growth

Return on equity

Ratios

Shareholding

F&O

Not in the F&O segment

Fund holders

Documents

Announcements

Events

Announcements

Not in the F&O segment

Announcements

Annual reports

Investor Presentation and earnings call

1

6

1

Compounded sales growth

Compounded profit growth

Return on equity

Gpt Healthcare Limited

About

Key insights

Key risks

Growth drivers

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Profit & loss

Balance sheet

Cash flow

Compounded returns

Compounded sales growth

Compounded profit growth

Return on equity

Ratios

Ratio timeline

Shareholding

Quarterly record

Bulk & block deals

Board and management

F&O

Not in the F&O segment

Fund holders

Documents

Announcements

Events

Announcements

Ratio timeline

Not in the F&O segment

Quarterly record

Bulk & block deals

Board and management

Announcements

Annual reports

Investor Presentation and earnings call

Upcoming and recent1

Dividends6

Board meetings1

Profit & loss

Balance sheet

Cash flow

Compounded returns

Compounded sales growth

Compounded profit growth

Return on equity

1

6

1